Valli De Re
Department of Molecular Oncology & Translational Medicine, National Cancer Institute
Dr. Valli De Re is a Faculty from Experimental and Clinical Pharmacology, Department of Molecular Oncology and Translational Medicine (DOMERT),Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Italy
Lymphoproliferations and cancer associated to inflammation due to chronic autoimmune diseases or virus infection. B and T-cell repertoire, BCR and TCR recognition, MHC molecules. In the last years combine molecular and proteomic approaches for the study of lymphoproliferative disorders associated with Hepatitis C virus infection and with chronic inflammation, identification and production of recombinant protein useful for bio-therapeutic approaches, identification of markers useful for early diagnosis of gastric carcinoma and for celiac disease complications.